Moderna Inc (NAS:MRNA)
$ 132.71 0.03 (0.02%) Market Cap: 50.86 Bil Enterprise Value: 43.56 Bil PE Ratio: 0 PB Ratio: 3.96 GF Score: 68/100

Q3 2021 Moderna Inc Earnings Call Transcript

Nov 04, 2021 / 12:00PM GMT
Release Date Price: $284.02 (-17.89%)
Operator

Good morning, and welcome to Moderna's Third Quarter Earnings Call. (Operator Instructions)

Please be advised that the call is being recorded. At this time, I'd like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please go ahead, ma'am.

Lavina Talukdar
Moderna, Inc. - Senior VP & Head of IR

Thank you, operator. Good morning, everyone, and thank you for joining us on today's call to discuss Moderna's third quarter 2021 financial results and business updates. You can access the press release we issued this morning as well as the slides that we'll be reviewing by going to the Investors section of our website.

On today's call are Stephane Bancel, our Chief Executive Officer; David Meline, our Chief Financial Officer; Stephen Hoge, our President; and Paul Burton, our Chief Medical Officer.

Before we begin, please note that this conference call will include forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Please see Slide

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot